Home Newsfeeds Oppenheimer Downgrades NextNav to Perform

Oppenheimer Downgrades NextNav to Perform

Oppenheimer analyst Timothy Horan downgrades NextNav (NASDAQ:NN) from Outperform to Perform.

byBenzinga Newsdesk

August 12, 2022

1 minute read

Oppenheimer analyst Timothy Horan downgrades NextNav (NASDAQ:NN) from Outperform to Perform.

Morgan Stanley Maintains Equal-Weight on Sarepta Therapeutics, Raises Price Target to $141

By Benzinga Newsdesk

October 13, 8:58 AM

Morgan Stanley analyst Matthew Harrison maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Equal-Weight and raises the price target from $135 to $141.

SRPT

Analyst Ratings

Decoding 7 Analyst Evaluations For Marriott Vacations

By Benzinga Insights

May 7, 1:00 PM

7 analysts have expressed a variety of opinions on Marriott Vacations (NYSE:VAC) over the past quarter, offering a…

VAC

Japan’s All Nippon Airways To Cut 30 Flights Per Day During January-March 2024: Here’s Why

By Shivani Kumaresan

October 31, 9:26 AM

Japan-based air transport and cargo services provider ANA Holdings Inc. (OTC: ALNPY) All Nippon Airways plans to begin a series of

ALNPY

Investor Sentiment Increases Further Following GDP Report; S&P 500 Gains For Sixth Day

By Avi Kapoor

January 26, 5:18 AM

The CNN Money Fear and Greed index showed further increase in overall market sentiment, while the index remained in the "Extreme Greed" zone on Thursday. U.S. stocks closed higher on Thursday, with the S&P 500 recording gains for the sixth consecutive day and notching another all-time closing record.

AAL

Oppenheimer Downgrades NextNav to Perform

Related Posts

Morgan Stanley Maintains Equal-Weight on Sarepta Therapeutics, Raises Price Target to $141

Decoding 7 Analyst Evaluations For Marriott Vacations

Japan’s All Nippon Airways To Cut 30 Flights Per Day During January-March 2024: Here’s Why

Investor Sentiment Increases Further Following GDP Report; S&P 500 Gains For Sixth Day